Predictors of Mesh Infection After Open Incisional Hernioplasty
1 other identifier
observational
62
1 country
1
Brief Summary
To determine the frequency of mesh infection in patient with open Incisional hernioplasty and to compare factors contributing with and without mesh infection
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 22, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 25, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 29, 2026
CompletedFirst Submitted
Initial submission to the registry
August 22, 2026
CompletedFirst Posted
Study publicly available on registry
August 27, 2026
CompletedAugust 27, 2026
August 1, 2026
10 months
August 22, 2026
August 25, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Number and percentage of participants with Mesh related infection following open Incisional hernioplasty
Development of mesh related infection following open Incisional hernioplasty assessed during postoperative followup will be accessed by clinical examination of the surgical site. The outcome will be measured as the number of participants who developed mesh related infection and percentage of mesh related infection.
1 month, 3 months and 1 year after surgery
Study Arms (1)
Mesh infection
Participants undergoing open Incisional hernioplasty who develop mesh related infection during the postoperative followup period
Eligibility Criteria
Patient of all age group and both genders with Incisional hernia undergoing open mesh hernioplasty will be consecutively enrolled and followed postoperative to access the development of mesh infection and associated predictors
You may qualify if:
- All age group patient will be included
- Both genders will be involved in this study
- Incisional hernia as per operational definition
You may not qualify if:
- Co- Morbid condition including hypertension, Tuberculosis and Autoimmune disease
- Parents refusing for consent
- Immunocompromised patient
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dr Faisal Masood teaching Hospital Sargodha
Sargodha, Punjab Province, 40100, Pakistan
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 22, 2026
First Posted
August 27, 2026
Study Start
September 22, 2025
Primary Completion
July 25, 2026
Study Completion
July 29, 2026
Last Updated
August 27, 2026
Record last verified: 2026-08